LifeMD, Inc.
LFMDNasdaqCIK 948320HealthcareFiscal year ends Dec 31
Reports and events: 225 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1514:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042691 |
| 2026-08-0520:51 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-036200 |
| 2026-08-0520:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036170 |
| 2026-06-2212:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029503 |
| 2026-05-0621:24 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-021536 |
| 2026-05-0621:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-021520 |
| 2026-04-3020:05 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001493152-26-020419 |
| 2026-03-1820:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-011228 |
| 2026-03-1020:56 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-009549 |
| 2026-03-0920:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009380 |
| 2026-01-0614:19 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-000525 |
| 2025-11-1721:52 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023906 |
| 2025-11-1721:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-023853 |
| 2025-11-0522:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020913 |
| 2025-11-0419:48 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020713 |
| 2025-08-2120:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-25-012214 |
| 2025-08-0520:46 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-022272 |
| 2025-08-0520:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-022258 |
| 2025-07-3120:36 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011523 |
| 2025-06-1620:43 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-015270 |
| 2025-05-0620:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-008864 |
| 2025-05-0620:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-008841 |
| 2025-04-2900:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-006539 |
| 2025-04-2820:30 ET | DEF 14A | Proxy statementPeriod 2025-04-28 | 0001641172-25-006444 |
| 2025-04-2520:33 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-006228 |
| 2025-03-1112:57 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-009790 |
| 2025-03-1020:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009690 |
| 2024-12-3114:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-052604 |
| 2024-12-2321:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-051819 |
| 2024-11-0721:45 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044032 |
| 2024-10-3123:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-043097 |
| 2024-08-0720:46 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030564 |
| 2024-06-1820:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-024278 |
| 2024-05-0820:45 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018250 |
| 2024-05-0220:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017571 |
| 2024-04-2920:59 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001493152-24-017032 |
| 2024-03-1120:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-009581 |
| 2023-12-1311:15 ET | 8-K | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-044648 |
| 2023-11-1421:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-041139 |
| 2023-11-0821:46 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-039923 |
| 2023-08-1010:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-027430 |
| 2023-08-0920:31 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027367 |
| 2023-07-3121:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-23-026121 |
| 2023-07-1420:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-024593 |
| 2023-07-0720:05 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-023977 |
| 2023-06-2221:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-022145 |
| 2023-06-2021:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-021726 |
| 2023-05-1213:24 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016516 |
| 2023-04-2813:11 ET | DEF 14A | Proxy statementPeriod 2023-04-28 | 0001493152-23-014083 |
| 2023-03-2300:12 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-008607 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:01 ET. Listed shows no prices and gives no investment advice.